Display options
Cite
Umeh OC, Currier JS. Sex Differences in HIV: Natural History, Pharmacokinetics, and Drug Toxicity. Curr Infect Dis Rep. 2005;7(1):73-78doi: 10.1007/s11908-005-0026-9.
Umeh, O. C., & Currier, J. S. (2005). Sex Differences in HIV: Natural History, Pharmacokinetics, and Drug Toxicity. Current infectious disease reports, 7(1), 73-78. https://doi.org/10.1007/s11908-005-0026-9
Umeh, Obiamiwe C, and Currier, Judith S. "Sex Differences in HIV: Natural History, Pharmacokinetics, and Drug Toxicity." Current infectious disease reports vol. 7,1 (2005): 73-78. doi: https://doi.org/10.1007/s11908-005-0026-9
Umeh OC, Currier JS. Sex Differences in HIV: Natural History, Pharmacokinetics, and Drug Toxicity. Curr Infect Dis Rep. 2005 Jan;7(1):73-78. doi: 10.1007/s11908-005-0026-9. PMID: 15610674.
Copy Download .nbib Format: NLM
Share it on

Curr Infect Dis Rep. 2005 Jan;7(1):73-78. doi: 10.1007/s11908-005-0026-9.

Sex Differences in HIV: Natural History, Pharmacokinetics, and Drug Toxicity.

Current infectious disease reports

Obiamiwe C Umeh, Judith S Currier

Affiliations

  1. Center for AIDS Research and Education, David Geffen School of Medicine at UCLA, BH-412 CHS, 10833 Le Conte Avenue, Los Angeles, CA 90095, USA. [email protected].

PMID: 15610674 DOI: 10.1007/s11908-005-0026-9

Abstract

In the early years of the HIV epidemic, the burden of the disease was principally among men. In recent years, HIV infection among women has become a growing problem worldwide. There is now an increasing awareness that HIV may affect men and women differently. New data have emerged from studies that have focused on HIV-infected women, suggesting the existence of sex-related differences in natural history, pharmacokinetics, and toxicity of antiretroviral therapy. This paper reviews the current literature with an emphasis on recent data regarding sex differences in HIV that have implications for clinical practice.

References

  1. AIDS. 1994 Jun;8(6):831-5 - PubMed
  2. MMWR Morb Mortal Wkly Rep. 2004 Feb 20;53(6):125-9 - PubMed
  3. J Womens Health Gend Based Med. 2002 Sep;11(7):601-15 - PubMed
  4. J Clin Pharm Ther. 1999 Oct;24(5):339-46 - PubMed
  5. J Infect Dis. 2004 Apr 1;189(7):1176-84 - PubMed
  6. Hepatology. 2003 Oct;38(4):978-88 - PubMed
  7. BMJ. 1994 Dec 10;309(6968):1537-42 - PubMed
  8. J Acquir Immune Defic Syndr. 2000 Aug 1;24(4):316-24 - PubMed
  9. Clin Infect Dis. 2002 Aug 1;35(3):313-22 - PubMed
  10. Clin Infect Dis. 2001 Jan;32(1):124-9 - PubMed
  11. J Acquir Immune Defic Syndr Hum Retrovirol. 1999 Apr 1;20(4):337-41 - PubMed
  12. Am J Med. 1996 Jul;101(1):34-40 - PubMed
  13. J Infect Dis. 1999 Sep;180(3):666-72 - PubMed
  14. J Acquir Immune Defic Syndr. 2003 Oct 1;34(2):184-90 - PubMed
  15. AIDS. 1999 Dec 24;13(18):2547-54 - PubMed
  16. J Acquir Immune Defic Syndr. 2002 Feb 1;29(2):197-202 - PubMed
  17. Eur J Obstet Gynecol Reprod Biol. 2003 Aug 15;109(2):199-205 - PubMed
  18. AIDS. 2002 Jul 26;16(11):1566-8 - PubMed
  19. Pharmacotherapy. 2004 May;24(5):592-9 - PubMed
  20. Psychol Med. 2002 Aug;32(6):1059-73 - PubMed
  21. J Acquir Immune Defic Syndr. 2000 Aug 15;24(5):475-82 - PubMed
  22. J Acquir Immune Defic Syndr. 2002 Sep 1;31(1):11-9 - PubMed
  23. AIDS. 2000 Oct 20;14(15):2355-60 - PubMed
  24. JAMA. 1994 Dec 28;272(24):1915-21 - PubMed
  25. Annu Rev Pharmacol Toxicol. 2004;44:499-523 - PubMed
  26. AIDS Read. 2001 Jan;11(1):29-33 - PubMed
  27. Cytometry B Clin Cytom. 2003 Mar;52(1):32-6 - PubMed
  28. J Acquir Immune Defic Syndr. 2003 Apr 1;32(4):452-61 - PubMed
  29. J Acquir Immune Defic Syndr. 2002 Jan 1;29(1):101-2 - PubMed
  30. AIDS. 1997 Jul;11(8):1071-3 - PubMed
  31. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001 May;91(5):546-51 - PubMed
  32. AIDS. 2003 Oct 17;17(15):2159-68 - PubMed
  33. AIDS. 1999 Dec 3;13(17):2361-4 - PubMed

Publication Types